Logo image of CGX-DB-B.CA

CINEPLEX INC (CGX-DB-B.CA) Stock Overview

Canada - TSX:CGX-DB-B - CA172454AC48

138 CAD
+5.85 (+4.43%)
Last: 10/16/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CGX-DB-B. CGX-DB-B was compared to 11 industry peers in the Entertainment industry. CGX-DB-B has a medium profitability rating, but doesn't score so well on its financial health evaluation. CGX-DB-B has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year CGX-DB-B has reported negative net income.
In the past year CGX-DB-B had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CGX-DB-B reported negative net income in multiple years.
CGX-DB-B had a positive operating cash flow in 4 of the past 5 years.
CGX-DB-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCGX-DB-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

CGX-DB-B has a Return On Assets of -2.72%. This is in the better half of the industry: CGX-DB-B outperforms 72.73% of its industry peers.
With an excellent Return On Invested Capital value of 4.56%, CGX-DB-B belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
CGX-DB-B had an Average Return On Invested Capital over the past 3 years of 3.36%. This is in line with the industry average of 4.45%.
The last Return On Invested Capital (4.56%) for CGX-DB-B is above the 3 year average (3.36%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -2.72%
ROE N/A
ROIC 4.56%
ROA(3y)1.91%
ROA(5y)-6.6%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.36%
ROIC(5y)N/A
CGX-DB-B.CA Yearly ROA, ROE, ROICCGX-DB-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

1.3 Margins

The Operating Margin of CGX-DB-B (7.92%) is better than 90.91% of its industry peers.
In the last couple of years the Operating Margin of CGX-DB-B has declined.
CGX-DB-B has a better Gross Margin (66.63%) than 90.91% of its industry peers.
In the last couple of years the Gross Margin of CGX-DB-B has remained more or less at the same level.
Industry RankSector Rank
OM 7.92%
PM (TTM) N/A
GM 66.63%
OM growth 3YN/A
OM growth 5Y-3.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.02%
GM growth 5Y0.37%
CGX-DB-B.CA Yearly Profit, Operating, Gross MarginsCGX-DB-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

3

2. Health

2.1 Basic Checks

CGX-DB-B has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CGX-DB-B has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CGX-DB-B remains at a similar level compared to 5 years ago.
Compared to 1 year ago, CGX-DB-B has an improved debt to assets ratio.
CGX-DB-B.CA Yearly Shares OutstandingCGX-DB-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CGX-DB-B.CA Yearly Total Debt VS Total AssetsCGX-DB-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 2.14 indicates that CGX-DB-B is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of CGX-DB-B (2.14) is better than 81.82% of its industry peers.
CGX-DB-B has a debt to FCF ratio of 22.36. This is a negative value and a sign of low solvency as CGX-DB-B would need 22.36 years to pay back of all of its debts.
CGX-DB-B has a Debt to FCF ratio of 22.36. This is in the better half of the industry: CGX-DB-B outperforms 63.64% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 22.36
Altman-Z 2.14
ROIC/WACC0.61
WACC7.48%
CGX-DB-B.CA Yearly LT Debt VS Equity VS FCFCGX-DB-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

CGX-DB-B has a Current Ratio of 0.31. This is a bad value and indicates that CGX-DB-B is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.31, CGX-DB-B is not doing good in the industry: 81.82% of the companies in the same industry are doing better.
A Quick Ratio of 0.28 indicates that CGX-DB-B may have some problems paying its short term obligations.
CGX-DB-B has a Quick ratio of 0.28. This is amonst the worse of the industry: CGX-DB-B underperforms 81.82% of its industry peers.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.28
CGX-DB-B.CA Yearly Current Assets VS Current LiabilitesCGX-DB-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for CGX-DB-B have decreased strongly by -375.00% in the last year.
Looking at the last year, CGX-DB-B shows a quite strong growth in Revenue. The Revenue has grown by 15.67% in the last year.
Measured over the past years, CGX-DB-B shows a decrease in Revenue. The Revenue has been decreasing by -4.39% on average per year.
EPS 1Y (TTM)-375%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.91%
Revenue 1Y (TTM)15.67%
Revenue growth 3Y26.54%
Revenue growth 5Y-4.39%
Sales Q2Q%30.46%

3.2 Future

Based on estimates for the next years, CGX-DB-B will show a very strong growth in Earnings Per Share. The EPS will grow by 51.80% on average per year.
CGX-DB-B is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.02% yearly.
EPS Next Y122.82%
EPS Next 2Y80.27%
EPS Next 3Y51.8%
EPS Next 5YN/A
Revenue Next Year4.57%
Revenue Next 2Y5.8%
Revenue Next 3Y5.02%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CGX-DB-B.CA Yearly Revenue VS EstimatesCGX-DB-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CGX-DB-B.CA Yearly EPS VS EstimatesCGX-DB-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CGX-DB-B. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 187.17 indicates a quite expensive valuation of CGX-DB-B.
Based on the Price/Forward Earnings ratio, CGX-DB-B is valued a bit cheaper than 63.64% of the companies in the same industry.
CGX-DB-B is valuated expensively when we compare the Price/Forward Earnings ratio to 22.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 187.17
CGX-DB-B.CA Price Earnings VS Forward Price EarningsCGX-DB-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 -100

4.2 Price Multiples

CGX-DB-B's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, CGX-DB-B is valued a bit cheaper than the industry average as 63.64% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 104.76
EV/EBITDA 35.95
CGX-DB-B.CA Per share dataCGX-DB-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

CGX-DB-B's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CGX-DB-B's earnings are expected to grow with 51.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y80.27%
EPS Next 3Y51.8%

More info and screens

0

5. Dividend

5.1 Amount

CGX-DB-B does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CINEPLEX INC

TSX:CGX-DB-B (10/16/2025, 7:00:00 PM)

138

+5.85 (+4.43%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-12 2025-08-12/bmo
Earnings (Next)11-06 2025-11-06
Inst Owners30%
Inst Owner ChangeN/A
Ins Owners1.97%
Ins Owner ChangeN/A
Market Cap8.75B
Analysts76
Price Target148.19 (7.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-91.04%
Min EPS beat(2)-153.04%
Max EPS beat(2)-29.05%
EPS beat(4)0
Avg EPS beat(4)-170.56%
Min EPS beat(4)-413.09%
Max EPS beat(4)-29.05%
EPS beat(8)2
Avg EPS beat(8)-677.12%
EPS beat(12)5
Avg EPS beat(12)-414.62%
EPS beat(16)7
Avg EPS beat(16)-307.21%
Revenue beat(2)1
Avg Revenue beat(2)-2.59%
Min Revenue beat(2)-5.38%
Max Revenue beat(2)0.2%
Revenue beat(4)2
Avg Revenue beat(4)-2.13%
Min Revenue beat(4)-5.38%
Max Revenue beat(4)1.26%
Revenue beat(8)4
Avg Revenue beat(8)-7.61%
Revenue beat(12)8
Avg Revenue beat(12)-4.23%
Revenue beat(16)11
Avg Revenue beat(16)-2.76%
PT rev (1m)-3.1%
PT rev (3m)-2.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.76%
EPS NY rev (1m)1.01%
EPS NY rev (3m)-71.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.13%
Revenue NY rev (1m)-0.56%
Revenue NY rev (3m)-2.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 187.17
P/S 6.32
P/FCF 104.76
P/OCF 56.39
P/B N/A
P/tB N/A
EV/EBITDA 35.95
EPS(TTM)-0.95
EYN/A
EPS(NY)0.74
Fwd EY0.53%
FCF(TTM)1.32
FCFY0.95%
OCF(TTM)2.45
OCFY1.77%
SpS21.82
BVpS-1.19
TBVpS-12.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.72%
ROE N/A
ROCE 6.33%
ROIC 4.56%
ROICexc 4.67%
ROICexgc 7.98%
OM 7.92%
PM (TTM) N/A
GM 66.63%
FCFM 6.04%
ROA(3y)1.91%
ROA(5y)-6.6%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.36%
ROIC(5y)N/A
ROICexc(3y)3.46%
ROICexc(5y)N/A
ROICexgc(3y)5.89%
ROICexgc(5y)N/A
ROCE(3y)4.66%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y2.1%
ROICexc growth 3YN/A
ROICexc growth 5Y0.06%
OM growth 3YN/A
OM growth 5Y-3.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.02%
GM growth 5Y0.37%
F-Score3
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 22.36
Debt/EBITDA 6.27
Cap/Depr 41.13%
Cap/Sales 5.18%
Interest Coverage 0.84
Cash Conversion 54.67%
Profit Quality N/A
Current Ratio 0.31
Quick Ratio 0.28
Altman-Z 2.14
F-Score3
WACC7.48%
ROIC/WACC0.61
Cap/Depr(3y)39.73%
Cap/Depr(5y)33.4%
Cap/Sales(3y)5.83%
Cap/Sales(5y)8.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-375%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.91%
EPS Next Y122.82%
EPS Next 2Y80.27%
EPS Next 3Y51.8%
EPS Next 5YN/A
Revenue 1Y (TTM)15.67%
Revenue growth 3Y26.54%
Revenue growth 5Y-4.39%
Sales Q2Q%30.46%
Revenue Next Year4.57%
Revenue Next 2Y5.8%
Revenue Next 3Y5.02%
Revenue Next 5YN/A
EBIT growth 1Y41.53%
EBIT growth 3YN/A
EBIT growth 5Y-7.81%
EBIT Next Year205.17%
EBIT Next 3Y54.92%
EBIT Next 5Y28.88%
FCF growth 1Y10.03%
FCF growth 3Y41.4%
FCF growth 5Y-13.75%
OCF growth 1Y-4.04%
OCF growth 3Y38.48%
OCF growth 5Y-12.79%